Article info
PDFCervical Cancer
Phase II Trial of Capecitabine and Cisplatin in Advanced, Persistent, or Recurrent Carcinoma of the Cervix
- Address correspondence and reprint requests to Ibrahim Elghissassi, MD, Department of Medical Oncology, National Institute of Oncology, Allal El-Fassi Street, 6213, Rabat, Morocco. E-mail: i_elghissassi{at}hotmail.com.
Citation
Phase II Trial of Capecitabine and Cisplatin in Advanced, Persistent, or Recurrent Carcinoma of the Cervix
Publication history
- Received October 1, 2010
- First published January 1, 2011.
Online issue publication
June 17, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2011 by IGCS and ESGO